Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.110
-0.090 (-4.09%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Nkarta Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
157
Market Cap
149.72M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
NKTX News
- 24 days ago - Nkarta to Participate in an April Investor Conference - GlobeNewsWire
- 25 days ago - Nkarta: Grinding Lower, Trying To Find Support - Seeking Alpha
- 25 days ago - Nkarta: Betting On The Turnaround - Seeking Alpha
- 4 weeks ago - Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? - Benzinga
- 4 weeks ago - Nkarta Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - GlobeNewsWire
- 2 months ago - Nkarta to Participate in March Investor Conferences - GlobeNewsWire
- 5 months ago - Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2 - GlobeNewsWire
- 5 months ago - Nkarta to Participate in an Upcoming Investor Conference - GlobeNewsWire